Weekly Spotlight - 12.12.24

Laryngeal MG is Best Diagnosed with a Tensilon Test or Pyridostigmine Trial

Subscribe | Follow us on LinkedIn đź”—

Community

We want to hear your story!

Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!

Latest News

Handling Uncomfortable Questions After an MG Diagnosis

Dealing with uncomfortable questions about your myasthenia gravis diagnosis can be challenging. This piece offers tips on how to handle curiosity, ignorance, or insensitive comments from others, suggesting preparation, setting boundaries, and seeking support from loved ones and support groups. It emphasizes the importance of self-care and confidence in managing these interactions.

Rare Thymic Mass Found in Elderly Patient with Muscle Weakness Disorder

A rare case of a thymic mass in an elderly male patient with myasthenia gravis is discussed, highlighting the unusual presentation and the importance of thorough diagnosis and treatment, as thymic abnormalities are more commonly associated with younger patients.

Phase 1 Trial of NKX019 CAR-NK Cell Therapy for GMG Cleared to Open

A Phase 1 trial for NKX019, a CAR-NK cell therapy, has been cleared to open. This treatment aims to enhance the body's natural killer cells to fight myasthenia gravis, offering a potential new therapeutic approach for managing the disease. The trial will assess the safety and efficacy of this innovative therapy.

New mRNA CAR-T Therapy Shows Promising Results in Treating Autoimmune Disorder

Cartesian Therapeutics' mRNA CAR-T therapy, known as Descartes-08, has shown promising results in treating myasthenia gravis by producing durable responses. The therapy involves using mRNA to instruct T cells to target and eliminate autoantibodies responsible for the disease, offering a potential new treatment option.

Health Spotlight’s Myasthenia Gravis is a Contentive publication in the Healthcare division